Emma Dean
Impact in
- Oncology top 2%
- PARP inhibition in cancer therapy
- Cancer-related Molecular Pathways
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism
- Cancer, Lipids, and Metabolism
Papers in
- Oncology 66
- PARP inhibition in cancer therapy 35
- Lung Cancer Research Studies 8
- Colorectal Cancer Treatments and Studies 7
-
- DNA Repair Mechanisms 26
- Cancer therapeutics and mechanisms 12
- Cell death mechanisms and regulation 11
- PI3K/AKT/mTOR signaling in cancer 8
- Co-authors
- Malcolm Ranson (29 shared papers)Caroline Dive (17 shared papers)Alastair Greystoke (14 shared papers)Mark R. Middleton (7 shared papers)Ruth Plummer (15 shared papers)Fiona Blackhall (9 shared papers)Simon A. Smith (21 shared papers)Helen Swaisland (4 shared papers)
- Journals
- Journal of Clinical Oncology (33 papers)Annals of Oncology (15 papers)Cancer Research (14 papers)British Journal of Cancer (11 papers)Clinical Cancer Research (5 papers)
- Partner nations
- United KingdomUnited StatesFrance
In The Last Decade
Emma Dean
132 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 102
- Oncology 1.4k
- Cancer Research 425
- Molecular Biology 1.7k
- Reproductive Medicine 155
- Pathology and Forensic Medicine 215
Countries citing papers authored by Emma Dean
This map shows the geographic impact of Emma Dean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emma Dean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emma Dean more than expected).
Fields of papers citing papers by Emma Dean
This network shows the impact of papers produced by Emma Dean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emma Dean. The network helps show where Emma Dean may publish in the future.
Co-authors
The 25 scholars most cited alongside Emma Dean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 136 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 209 | |
| 2 | 2019 | 193 | |
| 3 | 2020 | 131 | |
| 4 | 2008 | 114 | |
| 5 | 2012 | 108 | |
| 6 | 2016 | 106 | |
| 7 | 2015 | 105 | |
| 8 | 2021 | 93 | |
| 9 | 2021 | 86 | |
| 10 | 2018 | 84 | |
| 11 | 2021 | 78 | |
| 12 | 2009 | 77 | |
| 13 | 2019 | 70 | |
| 14 | 2007 | 64 | |
| 15 | 2021 | 63 | |
| 16 | 2022 | 63 | |
| 17 | 2021 | 60 | |
| 18 | 2023 | 45 | |
| 19 | 2015 | 42 | |
| 20 | 2007 | 41 |
About Emma Dean
Emma Dean is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research and Radiology, Nuclear Medicine and Imaging, having authored 136 papers that have together received 3.0k indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (35 papers), DNA Repair Mechanisms (26 papers), Lung Cancer Treatments and Mutations (15 papers), Cancer therapeutics and mechanisms (12 papers), Cell death mechanisms and regulation (11 papers), Lung Cancer Research Studies (8 papers), PI3K/AKT/mTOR signaling in cancer (8 papers) and Colorectal Cancer Treatments and Studies (7 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (425 citations), Molecular Biology (1.7k citations), Reproductive Medicine (155 citations) and Pathology and Forensic Medicine (215 citations). Emma Dean has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include Malcolm Ranson, Caroline Dive, Alastair Greystoke, Mark R. Middleton, Ruth Plummer, Fiona Blackhall, Simon A. Smith, Helen Swaisland, Johann S. de Bono and Peter G. Mortimer. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, British Journal of Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.